Rigel Pharmaceuticals | RIGL - Stock


Rigel Pharmaceuticals reported $13.3M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Amgen USD 6.19B 39M Mar/2026
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
AstraZeneca USD 6.57B 13M Mar/2026
BioMarin Pharmaceutical USD 1.27B 25.66M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Daiichi Sankyo JPY 608.55B 93.64B Sep/2025
Eli Lilly USD 14.53B 785M Mar/2026
Halozyme Therapeutics USD 155.47M 21.01M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Intrexon USD 287K 68K Dec/2022
Ionis Pharmaceuticals USD 5.56M 4.49M Mar/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Neurocrine Biosciences USD 64.5M 4.5M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Ultragenyx Pharmaceutical USD 55M 3M Mar/2026
Veracyte USD 21.42M 870K Mar/2026